Prostate cancer: some aspects of epidemiology, etiology and carcinogenesis for prostate cancer
- 作者: Al-Shukri S.K.1, Borovets S.Y.1
-
隶属关系:
- St.-Petersburg State Medical University named after acad. I. P. Pavlov
- 期: 卷 2, 编号 1 (2012)
- 页面: 23-25
- 栏目: Articles
- URL: https://journals.eco-vector.com/uroved/article/view/2547
- DOI: https://doi.org/10.17816/uroved2123-25
- ID: 2547
如何引用文章
详细
In the literature review some modern data concerning epidemiology, etiology and carcinogenesis for prostate cancer are contained based on the Russian and foreign scientific sources.
全文:
作者简介
Salman Al-Shukri
St.-Petersburg State Medical University named after acad. I. P. Pavlov
Email: al-shukri@mail.ru
doctor of medical science, professor, head of the department. Department of Urology
Sergey Borovets
St.-Petersburg State Medical University named after acad. I. P. Pavlov
Email: sborovets@mail.ru
doctor of medical science. Department of Urology
参考
- Давыдов М. И., Аксель Е. М. Статистика злокачественных новообразований в России и странах СНГ в 2004 году // Вестник РОНЦ им. Н. Н. Блохина РАМН. 2006. Т. 17, № 3. — 132 с.
- Аль-Шукри С. Х., Боровец С. Ю. Значимость мутаций гена BRG1 при рецидивировании рака предстательной железы после радикальной простатэктомии // Пленум правления Российского общества урологов: Материалы. Тюмень, 2005. С. 444.
- Аль-Шукри С. Х., Ткачук В. Н. Опухоли мочеполовых органов: Руководство для врачей. СПб.: Питер, 2000. 309 с.
- Al-Hajj M., Clarke M. F. Self-renewal and solid tumor stem cells // Oncogene. 2004. Vol. 23, № 43. P. 7274–7282.
- De Marzo A. M., Nelson W. G., Isaacs W. B., Epstein J. I. Pathological and molecular aspects of prostate cancer // Lancet. 2003. Vol. 361, Part 9361. P. 955–964.
- Dennis L. K., Lynch C. F., Torner J. C. Epidemiologic association between prostatitis and prostate cancer // Urology. 2002. Vol. 60, № 1. P. 78–83.
- Fox W. D., Higgins B., Maiese K. M. et al. Antibody to vascular endothelial growth factor slows growth of an androgen-independent xenograft model of prostate cancer // Clin. Cancer. Res. 2002. № 8. P. 3226–3231.
- Gittes R. F. Carcinoma of the prostate // N. Engl. J. Med. 1991. P. 1892–1893.
- Hanahan D., Weinberg R. A. The hallmarks of cancer // Cell. 2000. Vol. 7, № 100. P. 57–70.
- Hara T., Miyazaki H., Lee A. et al. Androgen receptor and invasion in prostate cancer // Cancer Res. 2008. Vol. 68, № 4. P. 1128–1135.
- Jemal A., Clegg L. X., Ward E. et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival // Cancer. 2004. Vol. 101, № 1. P. 3–27.
- Massard C., Deutch E., Soria J. Tumor stem cell-targeted treatment: limination or differentiation // Ann Oncol. 2006. Vol. 17, № 11. P. 1620–1624.
- Mimeault M., Batra S. K. Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies // Carcinogenesis. 2006. Vol. 27, № 1. P. 1–22.
- McNeal J. E., Alroy J., Leav I. et al. Immunohistochemical evidence for impaired cell differentiation in the premalignant phase of prostate carcinogenesis // Am. J. Clin. Pathol. 1988. Vol. 90, № 2. P. 23–32.
- Platz E. A., De Marzo A. M. Epidemiology of inflammation and prostate cancer // J. Urol. 2004. Vol. 171, № 2. P. 36–40.
- Sakr W. A., Billis A., Ekman P. et al. Epidemiology of high-grade prostatic intraepithelial neoplasia // Scand. J. Urol. Nephrol. 2000. Vol. 205, № 1. P. 11–18.
- Wingo P. A., Tong T., Bolden S. Cancer statistics // Cancer. J. Clin. 1995. Vol. 45, № 1. P. 8–30.
- Wingo P. A., Tong T., Bolden S. Cancer statistics // Cancer. J. Clin. 1995. Vol. 45, № 2. P. 127–128.